Metastatic Renal Cancer

13 clinical trials · Condition

Record	Firm	Date
Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma (NCT04316520)	University Hospital, Angers	2020-07-22
Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs (NCT03630692)	Institut Cancerologie de l'Ouest	2016-03-25
Everolimus Modulation of Anti-tumor T CD4 Immune Responses (NCT02837757)	Centre Hospitalier Universitaire de Besancon	2015-11-01
PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI (NCT02479490)	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	2015-09-22
Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma (NCT02086734)	Ludwig-Maximilians - University of Munich	2012-04-01
Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer (NCT01457131)	National Cancer Institute (NCI)	2011-10-06
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes (NCT01273181)	National Cancer Institute (NCI)	2010-12-01
Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer (NCT01160445)	National Cancer Institute (NCI)	2010-06-01

Every clearance here is in the API, with alerts when new ones post.